Cargando…
JMJD6 functions as an oncogene and is associated with poor prognosis in esophageal squamous cell carcinoma
BACKGROUND: Esophageal squamous cell carcinoma (ESCC) is one of the most common malignant tumors with a high prevalence and poor prognosis. It is an urgent problem to deeply understand the molecular mechanism of ESCC and develop effective diagnostic and prognostic methods. METHODS: Using tumor tissu...
Autores principales: | Liu, Honggang, Jiang, Menglong, Ma, Fenghui, Qin, Jiapei, Zhou, Xin, Xu, Liqun, Yan, Xiaolong, Jiang, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10367331/ https://www.ncbi.nlm.nih.gov/pubmed/37488513 http://dx.doi.org/10.1186/s12885-023-11171-z |
Ejemplares similares
-
EP300 as an oncogene correlates with poor prognosis in esophageal squamous carcinoma
por: Bi, Yanghui, et al.
Publicado: (2019) -
JMJD3 promotes esophageal squamous cell carcinoma pathogenesis through epigenetic regulation of MYC
por: Li, Shu-Man, et al.
Publicado: (2020) -
Phosphorylated AKT1 is associated with poor prognosis in esophageal squamous cell carcinoma
por: Zhu, Zhengfei, et al.
Publicado: (2015) -
Interleukin-8 and Interleukin-6 Are Biomarkers of Poor Prognosis in Esophageal Squamous Cell Carcinoma
por: Pastrez, Paula Roberta Aguiar, et al.
Publicado: (2023) -
JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer
por: Lee, Yi Fang, et al.
Publicado: (2012)